Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Female Reproductive SystemDRG 741-uterine-and-adnexa-procedures-for-non-ovarian-and-non-adnexal-malignancy-without-cc-mcc
    Ask Trek AI about this page

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    DRG 741 groups inpatient stays for uterine and adnexa procedures for non-ovarian and non-adnexal malignancy without Major Complication or Comorbidity or Complication or Comorbidity, defining the case mix for reimbursement. It matters for inpatient reimbursement because it determines payment classification and expected resource use for straightforward gynecologic oncology surgical admissions under Centers for Medicare & Medicaid Services.

    Customize your policy alerts

    Sign up for drg 741 policy alerts

    Get alerted when payer policies referencing 741 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 741 Overview

    DRG 741 covers inpatient hospital stays for uterine and adnexa procedures performed for non-ovarian and non-adnexal malignancy when there are no Major Complication or Comorbidity or Complication or Comorbidity present. Typical cases include hysterectomy and related surgical management of uterine or fallopian tube cancers without additional documented complications. This Diagnosis-Related Group is important for Medicare payment because it defines the payment grouping and relative resource use for straightforward malignant gynecologic procedures under Centers for Medicare & Medicaid Services reimbursement rules.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative approaches to minimize intraoperative blood loss and transfusion in patients undergoing hysterectomy or adnexal procedures for non-ovarian, non-adnexal uterine malignancies: randomized or pragmatic trials compare strategies such as enhanced hemostatic techniques, antifibrinolytic administration, and standardized surgical checklists in women scheduled for definitive surgery. The population includes adult women with uterine or other non-ovarian gynecologic malignancies without major comorbid complications (the DRG excludes CC/MCC), focusing on optimizing operative safety and reducing length of stay. This research is relevant to providers and payers because reducing transfusions, reoperations, and early complications can lower inpatient costs and resource utilization and improve bed turnover for this DRG cohort.
    • Comparative effectiveness studies of minimally invasive versus open surgical approaches for uterine and adnexa procedures in early-stage non-ovarian gynecologic malignancy: observational cohort studies or randomized trials evaluate perioperative outcomes, short-term morbidity, and readmission rates among patients without significant comorbidities. The target population is patients eligible for either approach who meet the DRG criteria (no CC/MCC), and the clinical question addresses trade-offs in operative time, complication profiles, and post-acute care needs. Results inform surgeons and payers about best practices that may reduce length of stay and post-discharge resource use, guiding case selection, care pathways, and reimbursement strategies.
    • Post-discharge recovery and health-service utilization studies examining quality of life, functional recovery, and unplanned healthcare use after discharge for women treated surgically for non-ovarian gynecologic malignancies: prospective cohort or registry-based studies track postoperative pain control, wound complications, outpatient visits, and readmissions over 30–90 days. These studies focus on the typical DRG population discharged without major complications and aim to identify predictors of readmission or extended recovery, including social determinants and discharge disposition. Findings are important to payers and health systems to design transitional care interventions, allocate post-acute resources, and develop bundled payment models that reflect expected utilization for this DRG group.

    Related Codes

    734-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITH-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy with CC/MCC: Inpatient Reimbursement Overview

    735-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITHOUT-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy: Inpatient Reimbursement Overview

    736-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    737-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    738-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    739-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    740-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    742-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITH-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy with CC/MCC: Inpatient Reimbursement Overview

    743-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy without CC/MCC: Inpatient Reimbursement Overview

    744-D-C-CONIZATION-LAPAROSCOPY-AND-TUBAL-INTERRUPTION-WITH-CC-MCC

    D&C, Conization, Laparoscopy and Tubal Interruption with CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 24

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.